Related Experiment Video

Updated: Jul 5, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions

Brigette B Y Ma1, Edwin P Hui, Anthony T C Chan

  • 1Department of Clinical Oncology at the Sir Y. K. Pao Center for Cancer, Prince of Wales Hospital, Ngan Shing Street, Shatin, New Territories, Hong Kong SAR, China.

Cancer Science
|May 24, 2008
PubMed

Insights

Systemic therapy advances non-keratinizing nasopharyngeal carcinoma (NPC) treatment. New research explores chemotherapy, targeted drugs, and Epstein-Barr virus (EBV) therapies, improving patient outcomes.

Area of Science:

  • Oncology
  • Virology
  • Immunotherapy

Background:

  • Non-keratinizing nasopharyngeal carcinoma (NPC) management relies heavily on systemic therapy.
  • Advances in understanding NPC pathogenesis and treatment resistance are crucial.

Purpose of the Study:

  • To review current clinical and translational research in NPC systemic therapy.
  • To highlight recent therapeutic advancements and their impact on patient outcomes.
  • To discuss future research directions in NPC treatment.

Main Methods:

  • Literature review of clinical trials and translational studies.
  • Analysis of chemotherapy, targeted therapy, and vaccine therapy data.
  • Evaluation of Epstein-Barr virus (EBV) DNA as a biomarker.

Main Results:

  • Chemotherapy shows efficacy in adjunctive treatment for locoregionally advanced NPC.
  • Novel targeted drugs and EBV-targeted vaccines represent promising therapeutic avenues.
  • Plasma EBV DNA serves as a valuable biomarker for patient selection and monitoring.

Conclusions:

  • Systemic therapy, including novel agents and biomarker-guided approaches, is transforming NPC management.
  • Continued research in targeted therapies and immunotherapy holds potential for further improving NPC patient survival.
  • Personalized treatment strategies based on biomarkers like EBV DNA are key to optimizing NPC care.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.